Hair Loss and Effectiveness
Yes, 66.3% of patients in the multi-center clinical study kept at least 50% of their hair. Typically, patients will start to see shedding (overall thinning ...
Tue, 17 Oct, 2017 at 12:55 PM
66.3% of patients using DigniCap in the multi-center clinical study kept at least 50% of their hair.
Tue, 17 Oct, 2017 at 11:46 AM
No. DigniCap prevents hair loss on the scalp area, where cooling is applied and therefore does not prevent eyebrow or eyelashes from thinning.
Tue, 17 Oct, 2017 at 11:47 AM
Cooling of the scalp is a proven approach to reduce chemotherapy-induced hair loss that has been used successfully by thousands of patients worldwide with ...
Tue, 17 Oct, 2017 at 1:11 PM
Scalp cooling has been evaluated mainly with regimens including anthracyclines (such as doxorubicin and epirubicin) and taxanes (such as paclitaxel and docet...
Tue, 17 Oct, 2017 at 1:18 PM
No. Scalp metastases is the development of secondary malignancy at a site away from the primary cancer growth. Scalp cooling does not increase this risk, ...
Tue, 17 Oct, 2017 at 1:26 PM